Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET February 20, 2008 to Discuss Fourth Quarter 2007 Results

WALTHAM, Mass., Feb. 13 Inverness MedicalInnovations, Inc. (Amex: IMA), a global leader in rapid point-of-carediagnostic products, today announced that it will release its fourth quarter2007 earnings on Wednesday, February 20, 2008. The Company will also host aconference call beginning at 10:00 a.m. (Eastern Time) on that date to discussthese results and other corporate matters. During the conference call theCompany may discuss and answer questions concerning business and financialdevelopments and trends. The Company's responses to questions, as well asother matters discussed during the conference call, may contain or constituteinformation that has not been disclosed previously.

The conference call can be accessed by dialing 973-582-2700 (domestic andinternational), an access code is not required, or via a link on the Invernesswebsite at www.invernessmedical.com. It is also available via link athttp://audioevent.mshow.com/342025/ using Real Player or Windows Media. Atelephone replay of the call will be available by dialing 706-645-9291(domestic and international) with an access code of 34933552. That replay willbe available until 12:00 midnight Eastern on February 23, 2008. An on-demandwebcast of the call will be available at the Inverness website(www.invernessmedical.com/News.cfm) two hours after the end of the call andwill be accessible for 30 days.

By developing new capabilities in near-patient diagnosis, monitoring andhealth management, Inverness Medical Innovations enables individuals to takecharge of improving their health and quality of life. A global leader inrapid point-of-care diagnostics, Inverness' products, as well as its newproduct development efforts, focus on infectious disease, cardiology,oncology, drugs of abuse and women's health. Inverness is headquartered inWaltham, Massachusetts.

For additional information on Inverness Medical Innovations, please visitwww.invernessmedical.com.

SOURCE Inverness Medical Innovations, Inc.

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...